HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 06, June 2018 – Cancer - Therapies and strategies for better patient outcomes       » Gardasil 9 supply running short in Hong Kong       » China helps Tajikistan tackle grassland degradation       » Immuno-oncology trials in China surge more than 50 per cent       » Yeast for industrial biotechnology       » Uncontrolled hypertension in rural communities      
EYE ON CHINA
China National Genebank and Smithsonian's National Museum of Natural History collaborate on biobanking to advance biodiversity research
China National Genebank (Shenzhen), also referred to as “CNGB-Shenzhen”, and National Museum of Natural History (NMNH), U.S.A. jointly announced that they have reached a strategic agreement to promote biorepository and genomics research, as well as to enhance the mutual exchanges of experience in resource collection and sharing, infrastructure construction and information management.

Biodiversity is increasingly recognized as critical to human life, from genetic diversity within a species to diversity within entire regions or ecosystems. However, many species are more threatened than ever by urbanization, global deforestation, climate change, industrial agricultural expansion and other human activities. To achieve the stable and sustainable development, it is important for all of us to preserve the biodiversity of life on earth for future research and discovery.

As a leading collections institution and the most visited natural history museum in the world, NMNH's collections total over 126 million specimens of plants, animals, fossils, minerals, rocks, meteorites, and human cultural artifacts. It also has traditionally taken on the role of supporting research through their collections, making them the natural leaders in the support of genomic research, such as the collaborative effort - Global Genome Initiative (GGI) - to preserve the genomic diversity of life on earth.

Under the agreement with NMNH, CNGB-Shenzhen established a Biological Resource Bank, an Information Database and a Network domestically and across the globe providing a powerful support for Omics-related scientific research and applications to promote the goals of biodiversity protection and sustainable development. With the approval and support of China National Development and Reform Commission and other national commissions, CNGB-Shenzhen was established in 2011, based on BGI-Shenzhen's robust technology platforms and computational infrastructure to analyze and store the massive OMICS data. By January 2013, CNGB-Shenzhen has collected more than one million biological samples including tissues, cells, blood, bodily fluids etc.

The partnership between CNGB-Shenzhen and NMNH will utilize both their expertise so as to better improve the biodiversity preservation and research. Under the agreement, two parties also will conduct scientific collaborations on the establishment of laboratory and data standards, data management, and professional training and education. Moreover, CNGB-Shenzhen will be responsible for providing high-throughput digitalization and informatics analysis, and management for advancing applications.

Dr. Jonathan Coddington, Associate Director of Research and Collections at NMNH, said, “The Global Genome Initiative is a Smithsonian-led effort to preserve the genomic diversity of life on Earth. As part of this program, NMNH is extremely pleased to partner with the China National Gene Bank (Shenzhen) to preserve and study comprehensive samples of Earth's genomic diversity. Together, we intend to support biodiversity genome science, to dramatically advance collection-based bioinformatics, to build the virtual, global biorepository, and to train the next generation of genomic scientists. We believe synoptic collections of quality genome samples will be an essential science infrastructure to address pressing human needs.”

Dr. Yong Zhang, Director of CNGB-Shenzhen, said, “It provides an unprecedented collaborative opportunity for NMNH and CNGB-Shenzhen to accelerate their growth, execute their global partnering strategy and support biodiversity research and development efforts. Combining two organizations’ world-leading expertise and extensive research experience in these fields, I believe we could seek more innovative solutions to better face the challenges of medical, environmental, energy, security, biodiversity protection and agricultural problems.”

Click here for the complete issue.

NEWS CRUNCH  
news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
Click here to receive APBN e-newsletters once a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Cancer - Therapies and strategies for better patient outcomes
July:
Water management / Vaccination
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy